NorthWest Biotherapeutics Inc (NWBO)

[f3tt3f]

F-stain bashing tweets have sunk to semantics:

Adam Feuerstein @adamfeuerstein
Larry Smith calls my recent $NWBO critique an "Attack Job." -> bit.ly/UCz9te I'll correct his errors later, taking kids skiing today
Details
14m


biorevolution @biorevolution
@adamfeuerstein did you ever correct his errors? Or are you pretty much giving up now that $NWBO got approval in Germany.
ViewConversation


Adam Feuerstein
@adamfeuerstein
. @biorevolution Germany didn’t approve DCVax. Reading comprehension is not your best skill. $NWBO


Does anyone with a twitter account want to advise F-stain to brush up on his reading comprehension?

from the PR:

NW Bio Announces Two German Approvals: “Hospital Exemption” for Early Access Program with DCVax-L and Eligibility of DCVax-L for Reimbursement

DCVax-L Is First Product of Its Kind to Receive Hospital Exemption from German Regulator

BETHESDA, Md., March 10, 2014 – Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that it has received approval from the Paul Ehrlich Institute (“PEI”- the FDA of Germany) of a “Hospital Exemption” early access program under Section 4b of the German Drug Law. Under this Hospital Exemption, NW Bio may provide DCVax-L to patients for the treatment of any glioma brain cancers (both Glioblastoma multiforme and lower grade gliomas), both newly diagnosed and recurrent, outside of the Company’s clinical trial and charge full price. The patients may be from Germany or elsewhere. This approval has a term of five years, and can be re-applied for and re-issued at the end